Vivos Therapeutics (VVOS) Treasury Shares (2026)

Vivos Therapeutics (VVOS) reported Treasury Shares of $1.8 million for Q1 2026.

Vivos Therapeutics (VVOS) Treasury Shares (2026) Analysis & Trends

Vivos Therapeutics (VVOS) has 1 years of Treasury Shares data on file, last reported at $1.8 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 256.42 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 263.29 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 83.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 26.40 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 4.51 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 900,000.00
10 Vivos Therapeutics 7.39 Mn 5.16 Mn 3.06 Mn 1.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.78 Mn
Mar 31, 2026 1.78 Mn